InterMune: Clinical Trials

4 trials sponsored by InterMune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4

Follow InterMune: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
Interferon gamma-1b ("Actimmune") - Idiopathic Pulmonary Fibrosis, Lung Disease
Phase 3TerminatedInterMune8262003-12-012009-07-02
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Interferon gamma-1b - Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis
Phase 3TerminatedInterMune912003-11-012007-11-06
A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
interferon-gamma 1b, azathioprine - Lung Disease, Pulmonary Fibrosis
Phase 3TerminatedInterMune2002-04-012007-11-06
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
Interferon gamma-1b - Ovarian Carcinoma, Peritoneal Carcinoma
Phase 3TerminatedInterMune8472001-10-012007-11-01

Conditions studied

Idiopathic Pulmonary Fibrosis (3)  ·  Lung Diseases (3)  ·  Pulmonary Fibrosis (3)  ·  Fibrosis (2)  ·  Carcinoma (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)

Interventions

interferon gamma-1b (3)  ·  Azathioprine (1)  ·  Interferon-gamma (1)

Countries

United States (3)  ·  Italy (1)

Top investigators

Steven Porter, MD (1)

Results publications

PMID 19570573, PMID 24311766, PMID 28657784, PMID 31047956, PMID 33434107, PMID 35688625, PMID 38238788